I've got some exciting news this morning. As you've probably noticed, there's a new name at the top of this email. Dr. Mark Stengler is one of the nation's leading holistic doctors and the author of 17 books on natural healing, including three best-sellers.

More importantly, he's also been my go-to guy whenever I have tough questions.

And just last week -- as he was explaining why the next wave of cholesterol meds will be even worse than the statins I've been warning you about -- it hit me.

"YOU should be writing House Calls!" I said.

"I'd love to," he answered. "What's the catch?"

"Well," I said. "It's a lot of hard work. There are a lot of readers who count on it. And the newsletter is completely free."

He looked me in the eye and repeated, "What's the catch?"

That's when I knew I found the right man for the job. So it's my honor to hand the keyboard over to him.

Hi, I'm Dr. Mark Stengler, and I believe that what makes my practice unique is the fact that I don't think in terms of "alternative" and "mainstream."

I'm not interested in playing semantics or choosing sides. As you'll see in House Calls, I'm only interested in the safest and most effective treatments for my patients -- and one of the areas where I combine the best elements of mainstream research with safe and natural alternative medicine is cholesterol control.

It's absolutely clear to me that LDL levels are an important marker of cardiovascular health, and you do need to keep them under control -- but you don't need statins or any other drugs to get there.

And you certainly won't need the next generation of cholesterol meds making their way to the market right now. The experimental meds, which are injected as infrequently as once a month, can slash LDL levels by almost two-thirds.

They're called PCSK9 inhibitors because they inhibit the protein (PCSK9) that prevents the liver from pulling cholesterol out of the blood. Once that protein is blocked, the liver starts gobbling up all that LDL -- to the point where even patients who already take statins have seen reductions of 60 percent or more.

That might sound great... but there's just one little problem here: Who on Earth needs to lower cholesterol by 60 percent anyway?

Answer: Practically nobody.

Mainstream targets for cholesterol have been set way too low. So low, in fact, that they're almost impossible to reach without meds. And sadly, I think that's the real goal here -- to sell more meds.

It's certainly not for better health, because the research clearly shows that the current targets actually come with more risks than benefits.

Since this is my first House Calls, I want to keep talking about cholesterol -- including some of those risks you'll face by bringing your levels down to meet guidelines.